Monday, March 23, 2026

Established Covered Call Position in Cardinal Health Inc.

I established a Covered Call net-debit limit order this morning in Cardinal Health (ticker CAH) at the $197.50 strike price for $194.80 per share.  Later today (with only 16 minutes remaining in this afternoon's trading session), my order was executed.  One hundred Cardinal Health shares were purchased at $206.35 and one April 10th, 2026 Call option was sold at $11.55 per share at the $197.50 strike price; so, the potential time value profit is $2.70 per share [$11.55 Call option premium - ($206.35 stock purchase price - $197.50 strike price)].  

This position uses my Dividend Capture Strategy (see details here) since there is an upcoming quarterly ex-dividend of $.5107 per share (annual dividend yield of 1.0%) on April 1st, 2026 which is prior to the April 10th options expiration date, so two potential return-on-investment results detailed below for this position includes this dividend income.    

As preferred by the Covered Calls Advisor, Cardinal Health's next quarterly earnings report on April 30th, 2026 will be after the April 10th options expiration date.  Given the Covered Calls Advisor's current Overall Market Meter indicator of Neutral, an in-the-money Covered Call position was established when the probability the stock is in-the-money on the options expiration date was 71.6%.

Cardinal Health is part of an oligopoly (along with McKesson and Cencora) that controls about 90% of U.S. drug and medical products distribution to hospitals, pharmacies, and health systems. 

Cardinal Health was the #1 ranked company (of only 16 total companies that met all criteria) in my custom Stock Rover stock screener using metrics obtained from O'Shaughnessy's book titled "What Works on Wall Street".  The details are: 


As detailed below, two potential return-on-investment results are: (1) +1.4% absolute return-on-investment (equivalent to +56.1% annualized return-on-investment over the next 9 days) if the stock is assigned on the day prior to the April 1st ex-dividend date; or (2) +1.6% absolute return-on-investment (equivalent to +33.4% annualized return-on-investment over the next 18 days) if the stock is assigned on the April 10th, 2026 options expiration date.

Cardinal Health Inc. (CAH) -- New Covered Call Position
The buy/write transaction today was as follows:
3/23/2026 Bought 100 Cardinal Health Inc. shares @ $206.35
3/23/2026 Sold 1 Cardinal Health 4/10/2026 $197.50 Call option @ $11.55 per share.  The implied volatility of this Call was 33.3 when this transaction was executed.  
4/1/2026 Upcoming quarterly ex-dividend of $.5107 per share

Two potential overall performance results (including commissions) for this Cardinal Health Covered Call position are as follows:
Covered Call Cost Basis: $19,480.67
= ($206.35 - $11.55) * 100 shares + $.67 commission

Net Profit Components:
(a) Option Income: +$1,154.33
= ($11.55 * 100 shares) - $.67 commissions
(b) Dividend Income (If CAH shares assigned on the day prior to the April 1st ex-dividend date): +$0.00
(b) Dividend Income (If CAH shares assigned at the April 10th, 2026 options expiration date): +$51.07
= ($.5107 dividend per share x 100 shares)
(c) Capital Appreciation (If Cardinal Health shares assigned on the day prior to the April 1st ex-dividend date): -$885.00
+($197.50 strike price - $206.35 stock purchase price) * 100 shares
(c) Capital Appreciation (If Cardinal Health shares assigned at the $197.50 strike price on the 4/10/2026 options expiration date): -$885.00
+($197.50 strike price - $206.35 stock purchase price) * 100 shares

1. Total Net Profit (If Cardinal Health shares assigned on the day prior to the April 1st ex-dividend date): +$269.33
= (+$1,154.33 option income + $0.00 dividend income - $885.00 capital appreciation)
2. Total Net Profit (If Cardinal Health shares assigned at the April 10th, 2026 options expiration date): +$320.40
= (+$1,154.33 option income + $51.07 dividend income - $885.00 capital appreciation)

1. Potential Absolute Return-on-Investment (If Cardinal Health shares assigned on the day prior to the April 1st ex-dividend date) : +1.4%
= +$269.33/$19,480.67
Potential Annualized Return-on-Investment: +56.1%
= (+$269.33/$19,480.67) * (365/9 days)
2. Potential Absolute Return-on-Investment (If Cardinal Health shares assigned at the April 10th, 2026 options expiration date): +1.6%
= +$320.40/$19,480.67
Potential Annualized Return-on-Investment: +33.4%
= (+$320.40/$19,480.67) * (365/18 days)

At least eight of the nine metrics used in the Covered Calls Advisor's Dividend Capture Strategy spreadsheet must be 'YES' prior to establishing a position.  As shown below with this Cardinal Health Inc. position, all nine criteria are met.

Closed Covered Calls Position in Global Payments Inc.

On last Friday's options expiration date, the Covered Calls position in Global Payments Inc.  (ticker GPN) closed out-of-the-money, so its Call options expired and the 400 shares remained in the Covered Calls Advisor Portfolio. Early in today's trading session I closed out this position at a net loss of $1,193.32 by selling the 400 shares of Global Payments at $70.28 which was below the original $75.00 strike price.  Along with other financial services companies, Global Payment's stock price has been punished since the start of the Iran War. The transactions history for this position and the associated return-on-investment results are detailed below.

Global Payments Inc. (GPN) -- Closed Out Covered Calls Position
The buy/write transaction was:
2/24/2026 Bought 400 Global Payments Inc. shares @ $78.63.
2/24/2026 Sold 4 GPN 3/20/2026 $75.00 Call options @ $5.11 per share.  The Implied Volatility of these Calls was 37.2% when this buy/write transaction occurred, which as preferred is well above the current 19.6% for the S&P 500 Volatility Index (i.e. VIX).
2/26/2026 Quarterly ex-dividend of $.25 per share.
3/20/2026 GPN closed out-of-the-money at $68.50 per share, so the Call options expired and the 400 Global Payments shares remained in the Covered Calls Advisor Portfolio.
3/23/2026 Closed out this Delta Covered Calls position by selling 400 GPN shares at $70.28.

The overall performance results (including commissions) for this Global Payments Inc. Covered Calls position are as follows:
Covered Calls Net Investment: $29,410.68
= ($78.63 - $5.11) * 400 shares + $2.68 commission

Net Profit Components:
(a) Options Income: +$2,046.68
= ($5.11 * 400 shares) - $2.68 commission
(b) Dividend Income: +$100.00
= ($.25 dividend per share x 400 shares)
(c) Capital Appreciation (400 GPN shares sold at $70.28 per share): -$3,340.00
+($70.28 stock selling price - $78.63 stock purchase price) * 400 shares

Total Net Loss: -$1,193.32
= (+$2,046.68 options income + $100.00 dividend income - $3,340.00 capital appreciation)

Absolute Return-on-Investment: -4.1%
= -$1,193.32/$29,410.68
Annualized Return-on-Investment: -54.9%
= (-$1,193.32/$29,410.68) * (365/27 days)

Saturday, March 21, 2026

March 20th, 2026 Options Expiration Results

The Covered Calls Advisor Portfolio had four Covered Calls positions with March 20th, 2026 options expiration dates.  Two positions (Expand Energy Corporation and NVIDIA Corporation) closed in-the-money. so their Calls expired and the shares were called away (i.e. sold) at their respective strike prices.  Two positions in Gilead Sciences Inc. and Global Payments Inc. closed out-of-the-money so their Call options expired and the shares remain in the Covered Calls Advisor Portfolio.  A summary of results for each of these positions (in alphabetical order) is as follows:

1. Expand Energy Corporation (EXE) -- +1.9% absolute return (equivalent to +28.3% annualized return-on-investment) for the 24 days of this investment.  This Covered Calls position was assigned at the $95.00 strike price since the stock closed in-the-money at $107.32 per share.  The original blog post detailing this Covered Calls position is here

2. Global Payments Inc. (GPN) -- This Covered Calls position closed yesterday at $68.50 which was well below its $75.00 strike price, so the four Call options expired and 400 Global Payments shares now remain in the Covered Calls Advisor Portfolio.  The original blog post detailing this position is here.  Early in this upcoming week I will decide to either continue this Covered Calls position by selling four Call options against the 400 Global Payments Inc. shares currently held or close out the position by selling these shares.

3. Gilead Sciences Inc. (GILD) -- This Covered Call position closed yesterday at $137.21 which was below its $140.00 strike price, so the one Call option expired and 100 Gilead shares now remain in the Covered Calls Advisor Portfolio.  The original blog post detailing this position is here.  Early in this upcoming week I will decide to either continue this Covered Call position by selling a Call option against the 100 Gilead shares currently held or close out the position by selling these shares. 

4. NVIDIA Corporation (NVDA) -- +1.9% absolute return (equivalent to +64.5% annualized return-on-investment) for the 11 days of this investment.  This Covered Call position was assigned at the $170.00 strike price since the stock closed in-the-money at $172.70 per share.  The original blog post detailing this Covered Call position is here.    

I welcome your feedback or questions at my email address shown below on anything related to the Covered Calls investing strategy.

Jeff Partlow
The Covered Calls Advisor
partlow@cox.net

Friday, March 20, 2026

Established Covered Calls in NVIDIA Corporation

Early in this morning's trading session, I established a short-term Covered Calls position of 13 days duration in NVIDIA Corporation (ticker NVDA).  My net buy/write limit order at $172.20 was executed by simultaneously purchasing two hundred shares at $177.13 and selling two April 2nd, 2026 Call options at $4.93 per share and at the $177.50 strike price. A slightly out-of-the-money strike price was established with the probability that NVIDIA's stock will close in-the-money (i.e. above the $177.50 strike price) on the 4/2/2026 options expiration date was 47.9% when this transaction was executed. 

NVIDIA reported their Q4 earnings after the market close three weeks ago. They substantially beat analysts' estimates on all relevant metrics including both earnings and revenue (which at $68.1 billion was 72.4% above the comparable quarter last year). In addition, their next quarter guidance at $78 billion is 76.9% above last year's result.  Two additional positives since their earnings report were the announcements at their GTC Conference and earlier this week an announcement of approval that shipments of their earlier generation H200 GPUs to approved companies in China can commence.  NVIDIA's stock has reacted negatively since then, but I agree with the numerous sell-side equity research firms that raised their NVIDIA post-earnings target prices.  The average target price of Wall Street analysts is now $264.57 (+49.4% above today's purchase price).  

As detailed below, a potential return-on-investment result if NVIDIA's share price is in-the-money (i.e. above the $177.50 strike price) and therefore assigned on its April 2nd, 2026 options expiration date is +3.1% absolute return-on-investment (equivalent to +86.3% annualized return-on-investment for the next 13 days).

NVIDIA Corporation (NVDA) -- New Covered Calls Position
Today's buy/write net limit order transaction was as follows:
3/20/2026 Bought 200 NVIDIA Corporation shares at $177.13.
3/20/2026 Sold 2 NVIDIA 4/2/2026 $177.50 Call options @ $4.93 per share.  The Implied Volatility of these Calls was 37.3 when this position was established, which is well above (as preferred) the VIX which was 25.0.  

A possible overall performance result (including commissions) for this NVIDIA Corporation Covered Calls position is as follows:
Covered Calls Net Investment: $34,441.34
= ($177.13 - $4.93) * 200 shares + $1.34 commission

Net Profit:
(a) Options Income: +$984.66
= ($4.93 * 200 shares) - $1.34 commission
(b) Dividend Income: +$0.00
(c) Capital Appreciation (If 200 NVIDIA shares assigned (i.e. above the $177.50 strike price) on the 4/2/2026 options expiration date): +$74.00
+($177.50 strike price - $177.13 stock purchase price) * 200 shares

Total Net Profit Potential (If 200 NVIDIA shares assigned at the $177.50 strike price on the 4/2/2026 options expiration date): +$1,058.66
= (+$984.66 options income + $0.00 dividend income + $74.00 capital appreciation)

Potential Absolute Return-on-Investment (If 200 NVIDIA shares assigned (i.e. sold) at the $177.50 strike price on the 4/2/2026 options expiration date): +3.1%
= (+$1,058.66/$34,441.34)
Potential Annualized Return-on-Investment: +86.3%
= (+$1,058.66/$34,441.34) * (365/13 days)